This is a PDF-only article. The first page of the PDF of this article appears below.
Current Issue
Article Tools
Share this Article
- Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E-Knockout MicePermalink:
Related Articles
Cited By...
- S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis
- ORMDL orosomucoid-like proteins are degraded by free-cholesterol-loading-induced autophagy
- All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity
- Sphingomyelin Depletion Impairs Anionic Phospholipid Inward Translocation and Induces Cholesterol Efflux
- Molecular Biology of Atherosclerosis
- Impaired Sphingolipid Synthesis in the Respiratory Tract Induces Airway Hyperreactivity
- Silencing of enzymes involved in ceramide biosynthesis causes distinct global alterations of lipid homeostasis and gene expression
- Ceramide Mediates Vascular Dysfunction in Diet-Induced Obesity by PP2A-Mediated Dephosphorylation of the eNOS-Akt Complex
- Cardiomyocyte Specific Deficiency of Serine Palmitoyltransferase Subunit 2 Reduces Ceramide but Leads to Cardiac Dysfunction
- Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity
- Selective Reduction in the Sphingomyelin Content of Atherogenic Lipoproteins Inhibits Their Retention in Murine Aortas and the Subsequent Development of Atherosclerosis
- Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition
- Association of Plasma Sphingomyelin Levels and Incident Coronary Heart Disease Events in an Adult Population: Multi-Ethnic Study of Atherosclerosis
- The SPTLC3 Subunit of Serine Palmitoyltransferase Generates Short Chain Sphingoid Bases
- Cell Polarity Factor Par3 Binds SPTLC1 and Modulates Monocyte Serine Palmitoyltransferase Activity and Chemotaxis
- Sphingomyelin Synthase 2 Is One of the Determinants for Plasma and Liver Sphingomyelin Levels in Mice
- An improved method to determine serine palmitoyltransferase activity
- PAQRs: A Counteracting Force to Ceramides?
- Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
- Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice
- Protection from High Fat Diet-induced Increase in Ceramide in Mice Lacking Plasminogen Activator Inhibitor 1
- Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice
- Sphingosine-1-Phosphate Analogue FTY720 Causes Lymphocyte Redistribution and Hypercholesterolemia in ApoE-Deficient Mice
- Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities
- Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers
- Assessment of Unstable Atherosclerosis in Mice
- Altered Adipose and Plasma Sphingolipid Metabolism in Obesity: A Potential Mechanism for Cardiovascular and Metabolic Risk
- Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice
- Plasma Sphingomyelin and Subclinical Atherosclerosis: Findings from the Multi-Ethnic Study of Atherosclerosis
- Hepatic Lipase Deficiency Delays Atherosclerosis, Myocardial Infarction, and Cardiac Dysfunction and Extends Lifespan in SR-BI/Apolipoprotein E Double Knockout Mice
- Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine
- Absorption and lipoprotein transport of sphingomyelin
- Lipoprotein Retention--and Clues for Atheroma Regression
- Effect of Myriocin on Plasma Sphingolipid Metabolism and Atherosclerosis in apoE-deficient Mice
- Sphingolipids and Atherosclerosis: A Mechanistic Connection? A Therapeutic Opportunity?